Genetic polymorphisms and cerebral palsy in very preterm infants

Pediatric Research

Volumn 57, Issue 4, 2005, Pages 494-499

  Nelson, Karin B ^a,e   Dambrosia, James M ^a   Iovannisci, David M ^b   Cheng, Suzanne ^c   Grether, Judith K ^d   Lammer, Edward ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETA 2 ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LYMPHOTOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CEREBRAL PALSY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; GESTATION PERIOD; HETEROZYGOTE; HISPANIC; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; POLYMORPHISM, GENETIC; PREGNANCY; THROMBOSIS;

EID: 15244346669     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000156477.00386.E7     Document Type: Article

References (18)

1. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L CSSCD Investigators 2004 Gene interactions and stroke risk in children with sickle cell anemia. Blood 103:2391-2396
2. Grether JK, Nelson KB, Walsh E, Willoughby RE, Redline RW 2003 Intrauterine exposure to infection and risk of cerebral palsy in very preterm infants. Arch Pediatr Adolesc Med 157:26-32
3. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP 1999 A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9:936-949
4. Freeman GH, Halton JH 1951 Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141-149
5. Breiman L, Friedman J, Olshen R, Stone C 1984 Classification and Regression Trees. Wadsworth, Pacific Grove
6. Lane DA, Grant PJ 2000 Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 1517-1532
7. Landau R, Xie HG, Dishy V, Stein CM, Wood AJ, Emala CW, Smiley RM 2002 Beta2-adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 187:1294-1298
8. Leviton A, Dammann O 2004 Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res 55:541-545
9. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290:2677-2684
10. Redline RW, Wilson-Costello D, Hack M 2002 Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 52:713-719
11. Hamvas A 2000 Disparate outcomes for very low birth weight infants: genetics, environment, or both? J Pediatr 136:427-428
12. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB 2000 Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 183:717-715
13. Hooper WC 2004 The relationship between inflammation and the anticoagulant pathway: the emerging role of endothelial nitric oxide synthase (eNOS). Curr Pharm Des 10:923-927
14. Bhagat K, Vallance P 1999 Effects of cytokines on nitric oxide pathways in human vasculature. Curr Opin Nephrol Hypertens 8:89-96
15. Voetsch B, Loscalzo J 2004 Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24:216-229
16. Levi M, Keller TT, van Gorp E, ten Cate H 2003 Infection and inflammation and the coagulation system. Cardiovasc Res 60:26-39
17. Cardon LR, Bell JI 2001 Association study designs for complex diseases. Nature Rev Genet 2:91-99
18. Colhoun HM, McKeigue PM, Davey Smith G 2003 Problems of reporting genetic associations with complex outcomes. Lancet 361:865-872